To investigate if the vasoactive systems adrenomedullin (ADM) and endothelin-1 (ET-1) are expressed in human adipose tissues in children and in adults and to determine the distribution pattern of nitric oxide synthases (NOS). DESIGN AND SUBJECTS: Subcutaneous, mesenterial and omental adipose tissue specimens taken from 15 children (age 0.5-16 y, median 6 y) and 13 adults (age 43-79 y, median 60 y) were analyzed. The body mass indices (BMI) were within the normal range. All patients were normotensive, and were free of infectious disease, and metabolic or endocrine disorders. The specimens were taken during elective laparotomies after informed consent was obtained. MEASUREMENTS: ADM, ET-1, the endothelial (eNOS) and inducible (iNOS) NOS as well as two housekeeping genes were measured using quantitative real-time PCR. RESULTS: ADM gene expression was found at all locations, and was significantly higher in adults than in children (Po0.01 for subcutaneous and omental adipose tissue). ET-1 mRNA was distributed in a similar way, showing significantly higher levels in the subcutaneous and mesenterial adipose tissue sections of adults than of children. For eNOS, the adult patients exhibited a higher expression in subcutaneous and mesenterial specimens than the children (Po0.01 and Po0.05). The iNOS mRNA was increased in subcutaneous, mesenterial and omental adipose tissues in the adult cohort compared to the children's levels (Po0.05 to Po0.01). CONCLUSION: Human adipose tissue expresses many vasoactive substances including ADM and ET-1. In adults, the amounts of ET-1 and ADM as well as eNOS and iNOS mRNA are higher, possibly due to a physiological upregulation with increasing age. Although there are differences depending on the locations of the tissues, the expression patterns of the antagonists ADM and ET-1 are quite similar, indicative of a well-balanced pattern of local gene expression in normotensive individuals with normal body weight.
Introduction
Human adipose tissue exhibits a variety of endocrine functions and contributes to the regulation of energy metabolism and vascular tone. Leptin, adiponectin, the renin-angiotensin system, steroid hormones and various cytokines are found in adipocytes and contribute to the metabolic homeostasis. 1 In the present study, we have tested if adrenomedullin (ADM) and endothelin-1 (ET-1) mRNAs could be found in the adipose tissues of children and adults obtained at three different locations (subcutaneous, omental and mesenterial) and how the nitric oxide synthases (NOS) are expressed transcriptionally in these tissues. ADM, originally detected in pheochromocytoma tissue, 2 is a vasodilative 52-amino-acid peptide. In general, ADM serves as an autocrine and paracrine regulator and also as a multifunctional hormone. In addition to its vasodilatory properties, ADM is natriuretic and diuretic, displays endocrine and metabolic functions such as the modification of aldosterone release and insulin secretion, 3, 4 and has various effects on cell proliferation and differentiation. 3, 5, 6 ADM gene expression and peptide production could be demonstrated in many types of normal and also in neoplastic cells. [7] [8] [9] [10] ADM binding sites are also found in various tissues; a shared receptor with calcitonin gene-related peptide (CGRP) could be characterized further as being regulated by specific receptor activity modifying proteins (RAMPS).
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ET-1 stimulates ADM expression in vascular smooth muscle cells (VSMC) as do the inflammatory cytokines, but the regulation profiles of these vasoactive substances are rather complex. 7 The functional ADM antagonist ET-1 is a potent vasoconstrictive 21-residue peptide, which was first described in vascular endothelial cells. 12 It is also expressed in various other types of cells and organs (such as blood vessels, heart, kidney, adrenal glands, lung and brain) and acts via two types of ET receptors, the ET-A and ET-B receptors, in a paracrine and autocrine manner. 13, 14 ET-1 has proliferative properties in smooth muscle cells and also promotes endocrine and metabolic functions, such as aldosterone or cortisol secretion. 14, 15 Additionally, it has been shown that ET-1 may stimulate leptin secretion in cultured adipocytes. 16 Short-time incubation of adipocytes with ET-1 also enhances the secretion of adiponectin, an insulin-sensitizing hormone, whereas a longer exposure time decreases the stimulatory effects of ET-1 and insulin on adipocyte-derived adiponectin secretion. 17 Nitric oxide (NO) is produced by many different cells via an enzymatic reaction catalyzed by one of the three isoforms of NOS, endothelial NOS (eNOS), inducible NOS (iNOS) or neuronal NOS (nNOS), depending on the cell type. NO is a potent vasodilator and mediator of inflammation, capable of exerting both cytoprotective and cytotoxic actions. As smooth muscle relaxant, NO and nNOS also play an important role in nitrergic neurotransmission. 18 NO is also implicated in the regulation of energy metabolism, possibly through the enhancement of mitochondria formation 19 or via the regulation of metabolic processes such as adipose tissue lipolysis 20 and glucose transport. 21 The expression of eNOS, and to a lesser extent of iNOS, in omental and subcutaneous adipose tissues has already been described in adults, and eNOS gene expression and protein levels were found to be higher in the omental tissue sections of obese patients. 22, 23 At present, there are no data available in the literature regarding the expression of ADM, ET-1, eNOS and iNOS in adipose tissue sections from different bodily locations in children; therefore, we have performed an initial trial investigating two groups, one pediatric and one adult.
Methods
The study was approved by the local ethics committee, and informed consent was obtained from the patients and/or their parents before collecting adipose tissue specimens (mean weight 0.5 g) during elective laparotomies (eg fundoplication, cholecystectomy, reversal of colostomies) from three different locations (subcutaneous, mesenterial and omental adipose tissue).
We have included 12 boys and three girls (age 0.5-16 y, median 6 y) and nine men and four women (age 43-79 y, median 60 y) in this study ( Figure 1 ). Their body mass indices (BMI) were within the normal range. The BMI ranged from 14.6 to 24.9 kg/m 2 (ie from the 3rd to 90th percentile for age and sex, mean 50th percentile) 24 in the children's group, and from 18.6 to 27.7 kg/m 2 (mean 23.2 kg/m 2 ) in the adult cohort. All participants were normotensive, were free of infectious diseases, did not suffer from metabolic or endocrine disorders and showed normal values for blood sugar and cholesterol. The samples were taken from the region of the primary subcutaneous incision and the operation field (omental from the Great Net, mesenterial from the mesenterial fat tissues near the intestine). The tissue specimens were immediately frozen in liquid nitrogen and stored at À801C until further analysis. Total RNA was isolated from 100 mg of adipose tissue, thereafter reverse transcription of 1 mg of RNA into the complementary DNA was performed according to standard procedures previously described. 18 We Distribution of the patient's age (y) and BMI (in actual percentiles for children, 24 and in kg/m 2 for adults). Data are given as box and whiskers: the box extends from the 25th to the 75th percentile, with a horizontal line at the median, and whiskers extend up to the largest and down to the smallest value. 0 (sense). Data were analyzed using GraphPad Prism s software 3.0 (San Diego, USA), and all values are given as mean 17standard error of the mean. To compare the patient groups, statistical analysis was performed using Student's ttest in the case of Gauss distribution, otherwise MannWhitney U-test was used. A P-value o0.05 was considered to be significant.
Results
ADM gene expression was found at all adipose tissue locations in both children and adults (Figure 2 ). It was significantly higher in adults than in children (for ADM/bactin Po0.01 for subcutaneous and omental adipose tissues).
We also detected ET-1 mRNA in all specimens (Figure 3 ). ET-1 gene expression was significantly higher in subcutaneous and mesenterial adipose tissue sections (Po0.01 and Po0.05, respectively) in adults than in children. In adults, ET-1-gene expression normalized to GAPDH or b-actin was significantly higher in subcutaneous than in omental tissue (Po0.05). Between the adipose tissues of children, no significant differences were observed.
It was interesting to observe that the expression pattern of the vasoconstrictor ET-1 was quite similar to the ADM data in our normotensive volunteers with normal weight, especially in adults, bearing in mind that ADM is a physiological ET-1 antagonist.
The quantities of eNOS and iNOS mRNA in adipose tissue were similar in our two groups in the absence of infectious diseases, with eNOS being only marginally higher than iNOS (Figures 4 and 5 ). For eNOS, the adult patients showed a higher expression in subcutaneous (Po0.01) and mesenterial localization (Po0.05) than the children (Figure 4) . The mRNA data for iNOS revealed significantly higher amounts in subcutaneous, mesenterial and omental adipose tissue specimens in the adult cohort than in the children's group (Po0.05 to Po0.01 for iNOS; Figure 5 ). All data were comparable for both of the housekeeping genes b-actin and GAPDH.
Discussion
We could demonstrate ADM gene expression in different adipose tissue sections in children and in adults and also found a higher expression in adults than in children. Although we did not measure peptide concentration directly, these data are indicative of ADM production in human adipose tissue containing adipocytes and stromal cells, since Vasoactive systems in adipose tissue I Knerr et al that ADM stimulates NO synthesis and vice versa. 27 In mice, deficiency of ADM leads to hypertension and a reduced lifespan; the reactive oxygen species in muscle are found to be increased whereas the insulin-stimulated glucose uptake was decreased in muscle. 28 ADM may therefore be considered as an endogenous peptide preserving insulin sensitivity with aging and the associated increased oxidative stress parameters. This could be a possible explanation for the higher ADM transcripts in the adults compared to the children in our study. ADM and ET-1 mRNA levels were found in a balanced pattern in our study groups. ET-1, one of the most potent vasoconstrictors, may also stimulate ADM secretion in vascular smooth muscle cells 7 and induce production of vasorelaxant NO in endothelial cells. 14 Human obesity and arterial hypertension are accompanied by elevated ET-1 concentrations in blood, and this chronic elevation of ET-1 may lead to downregulation of ET receptors. 14 In addition to these findings, the metabolic effects of ET-1 on adipocytes vary depending on the time of exposure. Long-time incubation of adipocytes with ET-1 decreases the acute stimulating ET-1 effects on adiponectin secretion, leading to an attenuated insulin-sensitizing effect. 17 Therefore, ET-1 appears to exert its metabolic effects not only through vasoconstriction and regulation of vascular tone but also directly, or via interaction with other adipocyte-derived hormones. Examples for such hormones are leptin, a signal hormone for the regulation of body fat and feeding behavior, and resistin, which plays a controversial role in the pathophysiology of insulin resistance. 16, 29, 30 Under cell culture conditions, ET-1 upregulates leptin production as efficaciously as insulin via the ET-A receptor. 16 In addition, ET-1 diminishes insulinstimulated and basal resistin secretion in vitro. 29 Adipocytes can be regarded as a target for circulating as well as for paracrine acting ET-1, also affecting the NO system. It has been shown that ET-1 inhibits the induction of iNOS mRNA and protein by tumor necrosis factor alpha in adipocytes. 31 In a former study, the expression of iNOS in subcutaneous tissue was found to be 10-fold lower than eNOS, while iNOS protein was not detected in lean persons and only at low concentrations in obese patients, 23 nNOS being undetectable. Our iNOS levels were comparable to those of eNOS, which might be due to the operative setting (general anesthesia, laparotomy). As shown in studies published earlier, eNOS seems to be the isoform of NOS predominantly expressed in human adipose tissues, irrespective of the localization, and may exert an important role in the regulation of lipolysis. However, the present research paper has certain limitations and further studies are necessary to clarify the differences between obese and lean persons, and also hypertensive obese and normotensive overweight patients. The correlation of the expression pattern of vasoactive peptides with different components and degrees of severity of the metabolic syndrome also requires further research. More functional data in addition to the observational measurements presented here would be of interest in order to gain more insight into the pathophysiology of the metabolic syndrome, and the regulatory influences and responses of adipose tissue derived vasoactive peptides in this setting.
Conclusion
In summary, we have shown that human adipose tissue expresses the vasoactive substances ADM and ET-1 in considerable amounts. Although there are differences due to the age of the patients and the location of the tissue in normotensive humans with normal body weight, the expression patterns of ADM and ET-1 were quite similar, indicative of a well-balanced pattern of local regulation of these peptides.
In the adults, the amounts of the mRNAs of ADM, eNOS and iNOS as well as of ET-1 were significantly higher than in the children, which could be due to a physiological upregulation or maturation in adipose tissues from childhood to adulthood.
However, to further clarify the possible role of adipocytederived vasoactive substances and to differentiate between adipocytes and stromal cells, it would be of interest to focus on the more functional aspects including adipose tissue biopsies of obese patients and hypertensive persons followed by in vitro studies of primary adipocytes with different degrees of differentiation and measurement of peptide levels in the cell supernatants.
